Selected research
Industry Research
Automated Biochip Analyzer Industry Research Report 2026
Market perspective
The global Automated Biochip Analyzer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Automated Biochip Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Automated Biochip Analyzer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Automated Biochip Analyzer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Automated Biochip Analyzer include Beijing ESSEN Technology, LifeTech Scientific Corporation, Yilson Medical Technology, MicroPort Scientific Corporation, Shandong Hua'an Biotechnology, Sino Medical, Lepu Medical Technology, Beijing Advanced Medical Technologies and Stentys SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Automated Biochip Analyzer market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Automated Biochip Analyzer Market by Company
Beijing ESSEN Technology
LifeTech Scientific Corporation
Yilson Medical Technology
MicroPort Scientific Corporation
Shandong Hua'an Biotechnology
Sino Medical
Lepu Medical Technology
Beijing Advanced Medical Technologies
Stentys SA
Medtronic
Boston Scientific
Biotronik AG
BD
B.Braun
Abbott
Automated Biochip Analyzer Segment by Type
Rapamycin Eluting Stent
Everolimus Eluting Stent
Others
Automated Biochip Analyzer Segment by Application
Hospitals
Clinic
Others
Automated Biochip Analyzer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Biochip Analyzer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated Biochip Analyzer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Biochip Analyzer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Automated Biochip Analyzer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Automated Biochip Analyzer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Automated Biochip Analyzer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rapamycin Eluting Stent
- Everolimus Eluting Stent
- Others
Applications
- Hospitals
- Clinic
- Others
Companies covered
- Beijing ESSEN Technology
- LifeTech Scientific Corporation
- Yilson Medical Technology
- MicroPort Scientific Corporation
- Shandong Hua'an Biotechnology
- Sino Medical
- Lepu Medical Technology
- Beijing Advanced Medical Technologies
- Stentys SA
- Medtronic
- Boston Scientific
- Biotronik AG
- BD
- B.Braun
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Automated Biochip Analyzer Market Size (2021-2032)
- 2.2.2 Global Automated Biochip Analyzer Sales (2021-2032)
- 2.2.3 Global Automated Biochip Analyzer Market Average Price (2021-2032)
- 2.3 Automated Biochip Analyzer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rapamycin Eluting Stent
- 2.3.3 Everolimus Eluting Stent
- 2.3.4 Others
- 2.4 Automated Biochip Analyzer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Automated Biochip Analyzer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Automated Biochip Analyzer Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Automated Biochip Analyzer Revenue of Manufacturers (2021-2026)
- 3.4 Global Automated Biochip Analyzer Average Price by Manufacturers (2021-2026)
- 3.5 Global Automated Biochip Analyzer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Automated Biochip Analyzer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Automated Biochip Analyzer, Product Type & Application
- 3.8 Global Manufacturers of Automated Biochip Analyzer, Established Date
- 3.9 Global Automated Biochip Analyzer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Beijing ESSEN Technology
- 4.1.1 Beijing ESSEN Technology Company Information
- 4.1.2 Beijing ESSEN Technology Business Overview
- 4.1.3 Beijing ESSEN Technology Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Beijing ESSEN Technology Automated Biochip Analyzer Product Portfolio
- 4.1.5 Beijing ESSEN Technology Recent Developments
- 4.2 LifeTech Scientific Corporation
- 4.2.1 LifeTech Scientific Corporation Company Information
- 4.2.2 LifeTech Scientific Corporation Business Overview
- 4.2.3 LifeTech Scientific Corporation Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 LifeTech Scientific Corporation Automated Biochip Analyzer Product Portfolio
- 4.2.5 LifeTech Scientific Corporation Recent Developments
- 4.3 Yilson Medical Technology
- 4.3.1 Yilson Medical Technology Company Information
- 4.3.2 Yilson Medical Technology Business Overview
- 4.3.3 Yilson Medical Technology Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yilson Medical Technology Automated Biochip Analyzer Product Portfolio
- 4.3.5 Yilson Medical Technology Recent Developments
- 4.4 MicroPort Scientific Corporation
- 4.4.1 MicroPort Scientific Corporation Company Information
- 4.4.2 MicroPort Scientific Corporation Business Overview
- 4.4.3 MicroPort Scientific Corporation Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MicroPort Scientific Corporation Automated Biochip Analyzer Product Portfolio
- 4.4.5 MicroPort Scientific Corporation Recent Developments
- 4.5 Shandong Hua'an Biotechnology
- 4.5.1 Shandong Hua'an Biotechnology Company Information
- 4.5.2 Shandong Hua'an Biotechnology Business Overview
- 4.5.3 Shandong Hua'an Biotechnology Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shandong Hua'an Biotechnology Automated Biochip Analyzer Product Portfolio
- 4.5.5 Shandong Hua'an Biotechnology Recent Developments
- 4.6 Sino Medical
- 4.6.1 Sino Medical Company Information
- 4.6.2 Sino Medical Business Overview
- 4.6.3 Sino Medical Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sino Medical Automated Biochip Analyzer Product Portfolio
- 4.6.5 Sino Medical Recent Developments
- 4.7 Lepu Medical Technology
- 4.7.1 Lepu Medical Technology Company Information
- 4.7.2 Lepu Medical Technology Business Overview
- 4.7.3 Lepu Medical Technology Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lepu Medical Technology Automated Biochip Analyzer Product Portfolio
- 4.7.5 Lepu Medical Technology Recent Developments
- 4.8 Beijing Advanced Medical Technologies
- 4.8.1 Beijing Advanced Medical Technologies Company Information
- 4.8.2 Beijing Advanced Medical Technologies Business Overview
- 4.8.3 Beijing Advanced Medical Technologies Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beijing Advanced Medical Technologies Automated Biochip Analyzer Product Portfolio
- 4.8.5 Beijing Advanced Medical Technologies Recent Developments
- 4.9 Stentys SA
- 4.9.1 Stentys SA Company Information
- 4.9.2 Stentys SA Business Overview
- 4.9.3 Stentys SA Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Stentys SA Automated Biochip Analyzer Product Portfolio
- 4.9.5 Stentys SA Recent Developments
- 4.10 Medtronic
- 4.10.1 Medtronic Company Information
- 4.10.2 Medtronic Business Overview
- 4.10.3 Medtronic Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medtronic Automated Biochip Analyzer Product Portfolio
- 4.10.5 Medtronic Recent Developments
- 4.11 Boston Scientific
- 4.11.1 Boston Scientific Company Information
- 4.11.2 Boston Scientific Business Overview
- 4.11.3 Boston Scientific Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Boston Scientific Automated Biochip Analyzer Product Portfolio
- 4.11.5 Boston Scientific Recent Developments
- 4.12 Biotronik AG
- 4.12.1 Biotronik AG Company Information
- 4.12.2 Biotronik AG Business Overview
- 4.12.3 Biotronik AG Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biotronik AG Automated Biochip Analyzer Product Portfolio
- 4.12.5 Biotronik AG Recent Developments
- 4.13 BD
- 4.13.1 BD Company Information
- 4.13.2 BD Business Overview
- 4.13.3 BD Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 BD Automated Biochip Analyzer Product Portfolio
- 4.13.5 BD Recent Developments
- 4.14 B.Braun
- 4.14.1 B.Braun Company Information
- 4.14.2 B.Braun Business Overview
- 4.14.3 B.Braun Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 B.Braun Automated Biochip Analyzer Product Portfolio
- 4.14.5 B.Braun Recent Developments
- 4.15 Abbott
- 4.15.1 Abbott Company Information
- 4.15.2 Abbott Business Overview
- 4.15.3 Abbott Automated Biochip Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Abbott Automated Biochip Analyzer Product Portfolio
- 4.15.5 Abbott Recent Developments
5 Global Automated Biochip Analyzer Market Scenario by Region
- 5.1 Global Automated Biochip Analyzer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Automated Biochip Analyzer Sales by Region: 2021-2032
- 5.2.1 Global Automated Biochip Analyzer Sales by Region: 2021-2026
- 5.2.2 Global Automated Biochip Analyzer Sales by Region: 2027-2032
- 5.3 Global Automated Biochip Analyzer Revenue by Region: 2021-2032
- 5.3.1 Global Automated Biochip Analyzer Revenue by Region: 2021-2026
- 5.3.2 Global Automated Biochip Analyzer Revenue by Region: 2027-2032
- 5.4 North America Automated Biochip Analyzer Market Facts & Figures by Country
- 5.4.1 North America Automated Biochip Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Automated Biochip Analyzer Sales by Country (2021-2032)
- 5.4.3 North America Automated Biochip Analyzer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Automated Biochip Analyzer Market Facts & Figures by Country
- 5.5.1 Europe Automated Biochip Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Automated Biochip Analyzer Sales by Country (2021-2032)
- 5.5.3 Europe Automated Biochip Analyzer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Automated Biochip Analyzer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Automated Biochip Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Automated Biochip Analyzer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Automated Biochip Analyzer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Automated Biochip Analyzer Market Facts & Figures by Country
- 5.7.1 South America Automated Biochip Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Automated Biochip Analyzer Sales by Country (2021-2032)
- 5.7.3 South America Automated Biochip Analyzer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Automated Biochip Analyzer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Automated Biochip Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Automated Biochip Analyzer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Automated Biochip Analyzer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Automated Biochip Analyzer Sales by Type (2021-2032)
- 6.1.1 Global Automated Biochip Analyzer Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Automated Biochip Analyzer Sales Market Share by Type (2021-2032)
- 6.2 Global Automated Biochip Analyzer Revenue by Type (2021-2032)
- 6.2.1 Global Automated Biochip Analyzer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Automated Biochip Analyzer Revenue Market Share by Type (2021-2032)
- 6.3 Global Automated Biochip Analyzer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Automated Biochip Analyzer Sales by Application (2021-2032)
- 7.1.1 Global Automated Biochip Analyzer Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Automated Biochip Analyzer Sales Market Share by Application (2021-2032)
- 7.2 Global Automated Biochip Analyzer Revenue by Application (2021-2032)
- 7.2.1 Global Automated Biochip Analyzer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Automated Biochip Analyzer Revenue Market Share by Application (2021-2032)
- 7.3 Global Automated Biochip Analyzer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Automated Biochip Analyzer Value Chain Analysis
- 8.1.1 Automated Biochip Analyzer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Automated Biochip Analyzer Production Mode & Process
- 8.2 Automated Biochip Analyzer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Automated Biochip Analyzer Distributors
- 8.2.3 Automated Biochip Analyzer Customers
9 Global Automated Biochip Analyzer Analyzing Market Dynamics
- 9.1 Automated Biochip Analyzer Industry Trends
- 9.2 Automated Biochip Analyzer Industry Drivers
- 9.3 Automated Biochip Analyzer Industry Opportunities and Challenges
- 9.4 Automated Biochip Analyzer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst